Longevity, decoded.
One protocol at a time.
Discover How SkinStim Can Enhance Your Health and Beauty
KidneyCell Files Patent for Precise Bioelectric Klotho Increase Up to 430%
Published: Mar 13, 2019 Device, programmed bioelectric signaling sequences and methods for the controlled expression of...
Read moreKidneyCell Announces Issuance U.S. Patent No. 10,646,644 May 12th, 2020 with 20 Years Patent Life for Bioelectric and Biologics Based Kidney Regeneration
Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including...
Read moreKidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure
The KidneyCell II Clinical Trial will feature non-invasive bioelectric stimulation controlled release of the Klotho protein...
Read moreLeonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions
Mission Viejo, California, United States, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, a Mission...
Read morePressureStim A Leonhardt Ventures Co. Announces Licensing of Patent Portfolio for Bioelectric Blood Pressure Management From Neuro Code Tech Holdings LLC Expanding Its Intellectual Property Estate.
Press Release – Santa Monica, California and Albuquerque, New Mexico, September 22nd, 2017 – PressureStim, an emerging...
Read moreLeonhardt Team Launches PressureStim Bioelectric Treatment of High Blood Pressure
PressureStim is designed to lower high blood pressure by improving elastic compliance of the aorta and...
Read moreLeonhardt’s Launchpads Accelerator To Showcase Eight Innovation Assets and Startups At 2022 Demo Day
Irvine, Calif., Nov. 16th, 2021 /PRDistribution/ -- Leonhardt's Launchpads announced today that they will showcase eight graduates of...
Read moreThe history of resonance therapy
The history of resonance therapy Download
Read moreLeonhardt’s Launchpads Accelerator Announces Demo Days and Showcases September in San Francisco and Palo Alto for Organ Regeneration and Recovery Focused Startups
Leonhardt's Launchpads www.leonhardtventures.com an innovation and startup accelerator focused exclusively on organ and tissue regeneration and...
Read moreMacular Degeneration
Age-Related Macular Degeneration (AMD) is one of the leading causes of severe vision loss and blindness...
Read moreMicrocurrent Stimulation for Macular Degeneration
Microcurrent stimulation for macular degeneration is one of many different therapies Dr. Edward Kondrot, MD. uses...
Read moreTAP Milestone II Report
Milestone II: “Identify where and how we will conduct live subject studies in which we will...
Read more